Overview

Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer

Status:
Terminated
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to determine if Iressa is effective in the treatment of Brain metastases from NCSLC
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Treatments:
Gefitinib